One in four GPs to rethink rep lunches

More than one-quarter of GPs say the pharmaceutical industry's plan to name doctors accepting free lunches and other payments will make them rethink their relationship with drug companies.

The findings, from an Australian Doctor online poll of 301 doctors, follow the release last month of a discussion paper from the industry's representative group, Medicines Australia, that outlined a plan to expose payments between its members and doctors.